Safety and persistence of the humoral and cellular immune responses induced by 2 doses of an AS03-adjuvanted A(H1N1)pdm09 pandemic influenza vaccine administered to infants, children and adolescents: Two open, uncontrolled studies

1. Garcia-Sicilia, J.
2. Arístegui, J.
3. Omeñaca, F.
4. Carmona, A.
5. Tejedor, J.C.
6. Merino, J.M.
7. García-Corbeira, P.
8. Walravens, K.
9. Bambure, V.
10. Moris, P.
11. Caplanusi, A.
12. Gillard, P.
13. Dieussaert, I.